☆ 4.5 Letter

Response to [Palmitoylethanolamide: one molecule, different formulations]

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2023)

Related references

Note: Only part of the references are listed.
Letter Clinical Neurology

Palmitoylethanolamide: One molecule, different formulations

Matteo Chiappedi

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2023)

Add to Collection
Article Clinical Neurology

Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial

Talieh Abedini et al.

Summary: This study suggests that palmitoylethanolamide can be an effective adjunctive medication in improving manic symptoms and clinical status in acute episodes of mania. However, further studies with larger sample sizes and longer follow-up therapy are needed to confirm these findings.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2022)

Add to Collection
Article Immunology

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain

Daniela Impellizzeri et al.

JOURNAL OF NEUROINFLAMMATION (2014)

Add to Collection
Article Engineering, Chemical

A control strategy for bioavailability enhancement by size reduction: Effect of micronization conditions on the bulk, surface and blending characteristics of an active pharmaceutical ingredient

Dolapo Olusanmi et al.

POWDER TECHNOLOGY (2014)

Add to Collection
Review Pharmacology & Pharmacy

Micron-size drug particles: Common and novel micronization techniques

N Rasenack et al.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2004)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.